Literature DB >> 20820781

Superiority of transcutaneous oxygen tension measurements in predicting limb salvage after below-the-knee angioplasty: a prospective trial in diabetic patients with critical limb ischemia.

Ulf Redlich1, Yan Y Xiong, Maciej Pech, Jörg Tautenhahn, Zuhir Halloul, Ralf Lobmann, Daniela Adolf, Jens Ricke, Oliver Dudeck.   

Abstract

PURPOSE: To assess postprocedural angiograms, the ankle-brachial index (ABI), and transcutaneous oxygen tension (TcPO₂) to predict outcome after infrageniculate angioplasty (PTA) in diabetic patients with critical limb ischemia (CLI) scheduled for amputation.
MATERIALS AND METHODS: PTA was performed in 28 diabetic patients with CLI confined to infrapopliteal vessels. We recorded patency of crural vessels, including the vascular supply of the foot as well as the ABI and TcPO₂ of the foot.
RESULTS: Technical success rate was 92.9% (n = 26), and limb-salvage rate at 12 months was 60.7% (n = 17). The number of patent straight vessels above and below the level of the malleoli increased significantly in patients avoiding amputation. Amputation was unnecessary in 88.2% (n = 15) patients when patency of at least one tibial artery was achieved. In 72.7% (n = 8) of patients, patency of the peroneal artery alone was not sufficient for limb salvage. ABI was of no predictive value for limb salvage. TcPO₂ values increased significantly only in patients not requiring amputation (P = 0.015). In patients with only one tibial artery supplying the foot or only a patent peroneal artery in postprocedural angiograms, TcPO₂ was capable of reliably predicting the outcome.
CONCLUSION: Below-the-knee PTA as an isolated part of therapy was effective to prevent major amputation in more than a half of diabetic patients with CLI. TcPO₂ was a valid predictor for limb salvage, even when angiographic outcome criteria failed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820781     DOI: 10.1007/s00270-010-9968-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Transcutaneous oxygen tension measurements following peripheral transluminal angioplasty procedure has more specificity and sensitivity than ankle brachial index.

Authors:  M Pardo; M Alcaraz; F L Bernal; J M Felices; G D Achel; M Canteras
Journal:  Br J Radiol       Date:  2014-11-28       Impact factor: 3.039

2.  [Long-term results after balloon angioplasty of crural arteries. Which factors influence leg salvage and survival rates?].

Authors:  I K Tesdal; C K Krzemien; C Weiss
Journal:  Radiologe       Date:  2016-03       Impact factor: 0.635

3.  The Role of Early Revascularization and Biomarkers in the Management of Diabetic Foot Ulcers: A Single Center Experience.

Authors:  Ettore Dinoto; Francesca Ferlito; Manfredi Agostino La Marca; Graziella Tortomasi; Francesca Urso; Salvatore Evola; Giovanni Guercio; Marco Marcianò; David Pakeliani; Guido Bajardi; Felice Pecoraro
Journal:  Diagnostics (Basel)       Date:  2022-02-19

4.  Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index.

Authors:  Carmine Gazzaruso; Adriana Coppola; Colomba Falcone; Chiara Luppi; Tiziana Montalcini; Elisabetta Baffero; Pietro Gallotti; Arturo Pujia; Sebastiano B Solerte; Gabriele Pelissero; Andrea Giustina
Journal:  Diabetes Care       Date:  2013-02-12       Impact factor: 19.112

5.  One Year Primary Patency of Infrapopliteal Angioplasty Using Drug- Eluting Balloons: Single Center Experience at King Hussein Medical Center.

Authors:  Sizeph Edward Haddad; Jan Mohammad Shishani; Izzeddin Qtaish; Mohammad Abdelmajeed Rawashdeh; Belal Saleh Qtaishat
Journal:  J Clin Imaging Sci       Date:  2017-08-03

6.  Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia.

Authors:  Bernard Leenstra; Joep Wijnand; Bart Verhoeven; Olivier Koning; Martin Teraa; Marianne C Verhaar; Gert J de Borst
Journal:  Angiology       Date:  2019-08-06       Impact factor: 3.619

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.